VS

Virendra Singh Chhoteraja Chauhan

Active Director Designated Partner DIN 10011459
DIN 10011459 First appointment Jul 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Virendra Singh Chhoteraja Chauhan

Data last updated:

Virendra Singh Chhoteraja Chauhan is a Designated Partner at Medicament Surgipharm Llp (since 2022). The company operates in Paper.

DIN 10011459
Primary Designation Designated Partner
Industry Paper
First Appointment 18 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Jul 20222022Active

Board colleagues of Virendra Singh Chhoteraja Chauhan

NameDINCompanyDesignation
Ruchit Bharatbhai Vyas10011460Medicament Surgipharm LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medicament Surgipharm Llp
Premium access

Shareholding and investment profile for Virendra Singh Chhoteraja Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Virendra Singh Chhoteraja Chauhan

Virendra Singh Chhoteraja Chauhan currently holds 1 directorship: Medicament Surgipharm Llp (Designated Partner, since 18 Jul 2022).

Virendra Singh Chhoteraja Chauhan was first appointed on 18 Jul 2022 as Designated Partner at Medicament Surgipharm Llp.

The current boards of Virendra Singh Chhoteraja Chauhan's companies include Ruchit Bharatbhai Vyas (Medicament Surgipharm Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available